Why write SQL queries when you can get an LLM to write the code for you? Query NFL data using querychat, a new chatbot ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move.

Joe Inzerillo is Salesforce's first CDO. His arrival comes as the agentic AI movement gets underway internally and externally.

In a fast-moving world, where it’s all about instant gratification, it should come as no surprise that Moses Itauma, at just 20 years of age, is already being talked about as Oleksandr Usyk’s next ...

On July 31, almost a month after sudden flood waters tore through her Big Sandy Creek home near Leander, Ashlee Willis sat at a long table at the Hill Country Youth Event Center outside Kerrville ...

VirtuallyZ Gaming, Microids Studio Paris, and Microids have announced that Syberia Remastered will launch on November 6, 2025 for PS5, PC, Xbox Series X/S. The PS5 and Xbox Series X/S versions will ...

The Conjuring franchise was already a massive success before its most recent entry, The Conjuring: Last Rites, had the biggest opening weekend in horror movie history. The film, which was billed as ...

The Dallas Mavericks' lease at American Airlines Center ends in 2031, and the team has indicated that it wants to move into a new home. Elías Valverde II / Staff Photographer Dallas hired a commercial ...

When the game times for Iowa’s first four games were released, the season opener against Albany kicking off at 5 p.m. stuck out like a sore thumb. It’s an odd kickoff time, breaking from the usual 11 ...

No rest for kings. That's what Ohio State is going through at the start of the 2025 season. The Buckeyes were the last team standing in 2024, lifting the national championship trophy in January after ...

Customs and Border Protection agents searched nearly 15,000 devices from April through June of this year, a nearly 17 percent spike over the previous three-month high in 2022. United States Custom and ...

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.